EnteroMedics Completes VBLOC Therapy Pre-PMA Meeting With FDA
ST. PAUL, MN--(Marketwired - May 17, 2013) - EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other...(more)
EnteroMedics
May 17, 2013 07:00 ET